Bioluminescence Ventures
Overview
Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine. We are inspired by the accelerating pace of biomedical innovation and its recent impact on human…
Investment Focus
- Transformational platform technologies
- First-in-class or best-in-class therapeutics programs
- Addressing major unmet medical needs
- Strong data packages
- Preference for leading investment rounds
- Efficient closing of rounds
Portfolio Companies
Reach Bioluminescence Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bioluminescence Ventures
What sectors does Bioluminescence Ventures invest in?
Bioluminescence Ventures invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in San Francisco, United States. Bioluminescence Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Bioluminescence Ventures invest at?
Bioluminescence Ventures backs companies at Series A, Series B, Growth, Late Stage and Pre-IPO.
Which regions does Bioluminescence Ventures invest in?
Bioluminescence Ventures invests across United States.
Who are the partners at Bioluminescence Ventures?
Team members listed for Bioluminescence Ventures include Angela Ni (Investment Partner - Healthcare Venture Capital) and Kouki Harasaki (Founding / Managing Partner).
What companies has Bioluminescence Ventures invested in?
Bioluminescence Ventures's portfolio includes Ensoma, ReCode Therapeutics, Nido Biosciences and SURGE Therapeutics.
How do I contact Bioluminescence Ventures?
Bioluminescence Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
